Status:
UNKNOWN
Comparing Strategies for Implementing Primary HPV Screening
Lead Sponsor:
Chun Chao
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Cervical Cancer
Human Papillomavirus
Eligibility:
All Genders
21-70 years
Phase:
NA
Brief Summary
Cervical cancer screening is an important component of women's health care. Most adult women are familiar with the conventional screening modality, Pap test, which has successfully reduced the burden ...
Detailed Description
Definition: Extended description of the protocol, including more technical information (as compared to the Brief Summary), if desired. Do not include the entire protocol; do not duplicate information ...
Eligibility Criteria
Inclusion
- This is a cluster randomized trial. All KPSC's 12 service areas except Orange Country will be randomized and included in this study. All providers (physicians, nurses and medical assistants) and department administrator from the primary care departments (family medicine and internal medicine) and the department of obstetrics and gynecology at these 12 service areas randomized to this arm will be included in the study, as well as female patients at these service areas between age 30-65 who received cervical cancer screening during the data collection period.
Exclusion
- Patients who are younger than 30 years old
- Providers working for departments other than Ob/Gyn, family or internal medicine
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
45000 Patients enrolled
Trial Details
Trial ID
NCT04371887
Start Date
March 1 2019
End Date
June 30 2023
Last Update
December 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Southern California
Pasadena, California, United States, 91101